2023 Q3 Form 10-Q Financial Statement

#000149315223028404 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $113.0K $204.4K
YoY Change -73.55% -55.85%
Cost Of Revenue $128.9K $101.7K
YoY Change -30.12% -32.41%
Gross Profit -$15.93K $102.7K
YoY Change -106.56% -67.14%
Gross Profit Margin -14.1% 50.24%
Selling, General & Admin $363.0K $716.6K
YoY Change -38.9% 176.79%
% of Gross Profit 697.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $23.75K $44.94K
YoY Change -53.21% -12.74%
% of Gross Profit 43.77%
Operating Expenses $515.7K $863.3K
YoY Change -37.82% 87.31%
Operating Profit -$402.7K -$658.9K
YoY Change 0.15% -31371.0%
Interest Expense $626.1K $44.14K
YoY Change
% of Operating Profit
Other Income/Expense, Net $626.1K $358.5K
YoY Change 5703.23% 15776.84%
Pretax Income $223.4K -$300.4K
YoY Change -157.09% -6981.58%
Income Tax
% Of Pretax Income
Net Earnings $223.4K -$300.4K
YoY Change -157.09% -6981.58%
Net Earnings / Revenue 197.68% -146.96%
Basic Earnings Per Share $0.02 -$0.03
Diluted Earnings Per Share $0.02 -$0.03
COMMON SHARES
Basic Shares Outstanding 10.91M shares 10.91M shares
Diluted Shares Outstanding 10.95M shares 10.90M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.456M $5.533M
YoY Change 14.37% 20.21%
Cash & Equivalents $4.456M $5.533M
Short-Term Investments
Other Short-Term Assets $101.9K $181.5K
YoY Change -5.17% 81.75%
Inventory
Prepaid Expenses
Receivables $350.8K $278.5K
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.909M $5.993M
YoY Change 16.26% 20.59%
LONG-TERM ASSETS
Property, Plant & Equipment $4.491M $4.513M
YoY Change -3.66% -4.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $4.390M $2.584M
YoY Change 254.95% 267.03%
Other Assets $3.167K $3.167K
YoY Change 0.0% 0.0%
Total Long-Term Assets $9.047M $7.280M
YoY Change 47.61% 28.58%
TOTAL ASSETS
Total Short-Term Assets $4.909M $5.993M
Total Long-Term Assets $9.047M $7.280M
Total Assets $13.96M $13.27M
YoY Change 34.82% 24.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $504.0K $79.68K
YoY Change 613.24% 102.41%
Accrued Expenses $17.08K $17.35K
YoY Change 6.4% 2.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $593.8K $167.2K
YoY Change 296.2% 42.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $152.9K $170.6K
YoY Change -35.09% -32.34%
Total Long-Term Liabilities $152.9K $170.6K
YoY Change -35.08% -32.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $593.8K $167.2K
Total Long-Term Liabilities $152.9K $170.6K
Total Liabilities $746.7K $337.8K
YoY Change 93.74% -8.58%
SHAREHOLDERS EQUITY
Retained Earnings -$74.00M -$74.00M
YoY Change 0.55% 1.09%
Common Stock $10.91K $10.91K
YoY Change 9.86% 9.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.21M $12.93M
YoY Change
Total Liabilities & Shareholders Equity $13.96M $13.27M
YoY Change 34.82% 24.85%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $223.4K -$300.4K
YoY Change -157.09% -6981.58%
Depreciation, Depletion And Amortization $23.75K $44.94K
YoY Change -53.21% -12.74%
Cash From Operating Activities $428.9K -$236.7K
YoY Change -347.16% -450.94%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.506M -$226.7K
YoY Change 182.54% -2.1%
Cash From Investing Activities -$1.506M -$226.7K
YoY Change 182.54% -2.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.000K 750.5K
YoY Change
NET CHANGE
Cash From Operating Activities 428.9K -236.7K
Cash From Investing Activities -1.506M -226.7K
Cash From Financing Activities 2.000K 750.5K
Net Change In Cash -1.077M 287.1K
YoY Change 52.41% -274.95%
FREE CASH FLOW
Cash From Operating Activities $428.9K -$236.7K
Capital Expenditures $0.00 $0.00
Free Cash Flow $428.9K -$236.7K
YoY Change -347.16% -450.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001156041
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
usd
us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Settlement Of Asset Retirement Obligations Through Noncash Payments Amount
SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount
usd
HUSA Changes In Accrued Equity Investment Contributions And Distributions
ChangesInAccruedEquityInvestmentContributionsAndDistributions
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Grants In Period Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriodExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercised In Period Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisedInPeriodExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Forfeited Or Expired In Period Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionForfeitedOrExpiredInPeriodExercisePrice
CY2023Q2 HUSA Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Warrant Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWarrantIntrinsicValue
usd
CY2023Q2 HUSA Sharebased Compensation Arrangement By Sharebased Payment Award Options Warrants Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWarrantsExercisableIntrinsicValue1
usd
CY2023Q2 HUSA Effect Of Common Stock Equivalents
EffectOfCommonStockEquivalents
usd
CY2022Q2 HUSA Effect Of Common Stock Equivalents
EffectOfCommonStockEquivalents
usd
HUSA Effect Of Common Stock Equivalents
EffectOfCommonStockEquivalents
usd
HUSA Effect Of Common Stock Equivalents
EffectOfCommonStockEquivalents
usd
CY2023Q2 HUSA Dilutive Effect Of Common Stock Equivalents Options And Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsAndWarrants
shares
HUSA Dilutive Effect Of Common Stock Equivalents Options And Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsAndWarrants
shares
HUSA Dilutive Effect Of Common Stock Equivalents Options And Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsAndWarrants
shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-32955
dei Entity Registrant Name
EntityRegistrantName
HOUSTON AMERICAN ENERGY CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0675953
dei Entity Address Address Line1
EntityAddressAddressLine1
801 Travis Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1425
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77002
dei City Area Code
CityAreaCode
(713)
dei Local Phone Number
LocalPhoneNumber
222-6966
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
HUSA
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10906353 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5532834 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4547210 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
278546 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
164575 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
181506 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
84544 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
5992886 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4796329 usd
CY2023Q2 HUSA Costs Subject To Amortization
CostsSubjectToAmortization
62774064 usd
CY2022Q4 HUSA Costs Subject To Amortization
CostsSubjectToAmortization
62786267 usd
CY2023Q2 HUSA Costs Not Being Amortized
CostsNotBeingAmortized
2343126 usd
CY2022Q4 HUSA Costs Not Being Amortized
CostsNotBeingAmortized
2343126 usd
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
90004 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
90004 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65207194 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65219397 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60693947 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60602051 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4513247 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4617346 usd
CY2023Q2 us-gaap Other Investments And Securities At Cost
OtherInvestmentsAndSecuritiesAtCost
2584086 usd
CY2022Q4 us-gaap Other Investments And Securities At Cost
OtherInvestmentsAndSecuritiesAtCost
2102139 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
179366 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
212202 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3167 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3167 usd
CY2023Q2 us-gaap Assets
Assets
13272752 usd
CY2022Q4 us-gaap Assets
Assets
11731183 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
79678 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
113741 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17354 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16035 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70183 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
65385 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
167215 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
195161 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
109967 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
146359 usd
CY2023Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
60587 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
72789 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
170554 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
219148 usd
CY2023Q2 us-gaap Liabilities
Liabilities
337769 usd
CY2022Q4 us-gaap Liabilities
Liabilities
414309 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10906353 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10906353 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10327646 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10327646 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
10907 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10328 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
86908002 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85094266 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73983926 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73787720 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
12934983 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11316874 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13272752 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11731183 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
434414 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
886809 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
204390 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
462989 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
215400 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
311757 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
101714 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
150485 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1046434 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
628996 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
716615 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
258896 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
91896 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
109740 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44941 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
51501 usd
us-gaap Operating Expenses
OperatingExpenses
1353730 usd
us-gaap Operating Expenses
OperatingExpenses
1050493 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
863270 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
460882 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-919316 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-163684 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-658880 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2107 usd
us-gaap Interest Income Other
InterestIncomeOther
74635 usd
us-gaap Interest Income Other
InterestIncomeOther
2489 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
44135 usd
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
2258 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
648475 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
314364 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
723110 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2489 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
358499 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2258 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-196206 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-161195 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-300381 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4365 usd
us-gaap Net Income Loss
NetIncomeLoss
-196206 usd
us-gaap Net Income Loss
NetIncomeLoss
-161195 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-300381 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
4365 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10659076 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9923338 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10896996 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9923338 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11316874 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
84445 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
901500 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
104175 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
12406994 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
77870 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
750500 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-300381 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
12934983 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10311943 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85485 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-165560 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
10231868 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
10231868 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25520 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
4365 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
4365 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10261753 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10261753 usd
us-gaap Net Income Loss
NetIncomeLoss
-196206 usd
us-gaap Net Income Loss
NetIncomeLoss
-161195 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
91896 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
109740 usd
us-gaap Accretion Expense
AccretionExpense
2678 usd
us-gaap Accretion Expense
AccretionExpense
3697 usd
us-gaap Share Based Compensation
ShareBasedCompensation
162315 usd
us-gaap Share Based Compensation
ShareBasedCompensation
111005 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
32836 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
30169 usd
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
648475 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
113971 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
52164 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-534155 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
14467 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-51101 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-24552 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-31594 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-31594 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-217467 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29361 usd
us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
14162 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
448909 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
248282 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-448909 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-262444 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1652000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1652000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
985624 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-291805 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4547210 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4894577 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5532834 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4602772 usd
us-gaap Settlement Of Asset Retirement Obligations Through Noncash Payments Amount
SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount
1259 usd
HUSA Changes In Accrued Equity Investment Contributions And Distributions
ChangesInAccruedEquityInvestmentContributionsAndDistributions
33038 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zkZ2TA55ZTf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zAXgZ5B8nNc3">Accounting Principles and Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. In preparing financial statements, management makes informed judgments and estimates that affect the reported amounts of assets and liabilities as of the date of the financial statements and affect the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management reviews its estimates, including those related to such potential matters as litigation, environmental liabilities, income taxes and the related valuation allowance, determination of proved reserves of oil and gas and asset retirement obligations. Changes in facts and circumstances may result in revised estimates and actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2023Q2 us-gaap Depletion
Depletion
44941 usd
us-gaap Depletion
Depletion
79640 usd
CY2022Q2 us-gaap Depletion
Depletion
91896 usd
us-gaap Depletion
Depletion
109740 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zVa4Th9p3VQf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zmKBpPvst1ok">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to a concentration of credit risk include cash, cash equivalents (if any) and any marketable securities (if any). The Company had cash deposits of $<span id="xdx_900_eus-gaap--Deposits_iI_pn5n6_c20230630_zZony8mFPnl5" title="Cash deposits">5.1</span> million in excess of the FDIC’s current insured limit on interest bearing accounts of $<span id="xdx_904_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230630_zaQOCJnR7tK5" title="Cash FDIC insured amount">250,000</span> as of June 30, 2023. The Company also had cash deposits of $<span id="xdx_903_eus-gaap--Deposits_iI_pp0p0_c20230630__us-gaap--CreditFacilityAxis__custom--ColombianBankMember_zWbgUTqCWz03" title="Cash deposits">5,500</span> in Colombian banks at June 30, 2023 that are not insured by the FDIC. The Company has not experienced any losses on its deposits of cash and cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Deposits
Deposits
5100000 usd
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
204390 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
462989 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
434414 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
886809 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
434414 usd
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
4513247 usd
us-gaap Costs Incurred Acquisition Of Oil And Gas Properties
CostsIncurredAcquisitionOfOilAndGasProperties
481947 usd
us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
648475 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
944177 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.08
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
60000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.09
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1004177 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.45
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
286160 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
958851 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.46
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
284240 usd
us-gaap Share Based Compensation
ShareBasedCompensation
162315 usd
us-gaap Share Based Compensation
ShareBasedCompensation
111005 usd
HUSA Earnings Per Share Effect Of Share Based Compensation Expense Basic
EarningsPerShareEffectOfShareBasedCompensationExpenseBasic
-0.02
HUSA Earnings Per Share Effect Of Share Based Compensation Expense Diluted
EarningsPerShareEffectOfShareBasedCompensationExpenseDiluted
-0.02
HUSA Earnings Per Share Effect Of Share Based Compensation Expense Basic
EarningsPerShareEffectOfShareBasedCompensationExpenseBasic
-0.01
HUSA Earnings Per Share Effect Of Share Based Compensation Expense Diluted
EarningsPerShareEffectOfShareBasedCompensationExpenseDiluted
-0.01
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
94400 shares
CY2022Q4 HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Exercise Price Rage Number Of Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingExercisePriceRageNumberOfShare
2.46
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
94400 shares
CY2023Q2 HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Exercise Price Rage Number Of Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingExercisePriceRageNumberOfShare
2.46
CY2023Q2 HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
94400 shares
CY2023Q2 HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingExercisableWeightedAverageExercisePrice
2.46 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-300381 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
4365 usd
us-gaap Net Income Loss
NetIncomeLoss
-196206 usd
us-gaap Net Income Loss
NetIncomeLoss
-161195 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-300381 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4365 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-196206 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-161195 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10896996 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9923338 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10659076 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9923338 shares
CY2022Q2 HUSA Dilutive Effect Of Common Stock Equivalents Options And Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsAndWarrants
455953 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10896996 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10379291 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10659076 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9923338 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1098577 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
168400 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1098577 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1084577 shares
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
43770 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
88801 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
75051 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
207622 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
27472 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
180150 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70183 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
109967 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
179366 usd
CY2023Q2 us-gaap Payments For Rent
PaymentsForRent
22570 usd
CY2022Q2 us-gaap Payments For Rent
PaymentsForRent
22161 usd
us-gaap Payments For Rent
PaymentsForRent
45731 usd
us-gaap Payments For Rent
PaymentsForRent
46836 usd

Files In Submission

Name View Source Status
0001493152-23-028404-index-headers.html Edgar Link pending
0001493152-23-028404-index.html Edgar Link pending
0001493152-23-028404.txt Edgar Link pending
0001493152-23-028404-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
husa-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
husa-20230630_cal.xml Edgar Link unprocessable
husa-20230630_def.xml Edgar Link unprocessable
husa-20230630_lab.xml Edgar Link unprocessable
husa-20230630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed